CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more …

Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and …

Our parent company, CSL, headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

CSL is committed to protecting public health and improving and saving the lives of patients with rare and serious diseases through the development, manufacture and reliable supply of high …

CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with nearly 330 plasma donation centers globally, including the U.S. and Europe …

Nov 18, 2025 · The CSL Seqirus site in Tullamarine, Melbourne, will be capable of supplying Australia with cell-based flu vaccine and meeting future demand from Asia, Europe, the Middle …

CSL was established in Australia in 1916. Over the ensuing years, CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines …

CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.

CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases.

CSL is committed to putting the patient first in all that we do to discover, develop, and deliver biotherapeutics and vaccines that meet their needs. We know that every patient is someone’s …